首頁
Ascentage Pharma Group Inc

7月 2026Ascentage Pharma Group Inc的市場佔有率分析

ROCKVILLE, Md. and SUZHOU, China, May 21, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, today announced that six abstracts from its clinical studies, selected for presentation Read More ›

行業: N/A

域名ascentage.com

成立年份2009

僱員501 - 1000

年度營收$25M - $50M

Ascentage Pharma Group Inc

Ascentage Pharma Group Inc（包含公司地區）

ascentage.com

查看更多網站流量與參與度資訊

Ascentage Pharma Group Inc截至 7月 2026 的總收入為 25M - 50M

Ascentage Pharma Group Inc 熱門網域產生的總收入

Ascentage Pharma Group Inc 熱門網域 3 年內的總收入

Ascentage Pharma Group Inc 熱門網域的總收入

ascentage.com25M - 50M

透過銷售情報查看更多內容

Ascentage Pharma Group Inc的熱門網域總造訪量

了解Ascentage Pharma Group Inc市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

ascentage.com4K

透過銷售情報查看更多內容

Ascentage Pharma Group Inc的熱門網域平均造訪時長

分析Ascentage Pharma Group Inc參與度指標。

過去 3 個月平均造訪時長

子公司細目

ascentage.com00:01:07

透過銷售情報查看更多內容

Ascentage Pharma Group Inc的熱門網域平均頁面瀏覽量

了解Ascentage Pharma Group Inc如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

ascentage.com2.23

透過銷售情報查看更多內容

Ascentage Pharma Group Inc按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術Ascentage Pharma Group Inc

这些是Ascentage Pharma Group Inc顶级域名使用的行业网站技术

付款與貨幣 (10)

Cart Functionality

電子商務 (4)

OpenCart

加密貨幣 (3)

Bitcoin Acceptance

市場行銷 (2)

Google Marketing Platform

更多技術

7

檢視所有

新聞與訊號來自Ascentage Pharma Group Inc

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Ascentage Pharma Group had revenue of $22.2M on Aug 21st '26.* Ascentage reported a quarterly loss of $0.65 per share on $22.24 million in revenue, while institutional investors including UBS, HSBC, and Citadel recently established or increased positions.

新聞Ascentage Pharma Group had revenue of $44.8M on Jun 30th '26.Ascentage Pharma Group International reported total revenue of RMB302.2m for the six months ended June 30, 2026, up 29.3% compared to RMB233.7m in the prior-year period.

新聞Ascentage Pharma Group partners with Merck Group.Leveraging its robust R&D capabilities, Ascentage Pharma has built a portfolio of global intellectual property rights and entered into global partnerships and other relationships with numerous leading biotechnology and pharmaceutical companies, such as Takeda, AstraZeneca, Merck, Pfizer, and Innovent, in addition to research and development relationships with leading research institutions, such as Dana-Farber Cancer Institute, Mayo Clinic, National Cancer Institute and the University of Michigan.